naproxen has been researched along with Ectopic Ossification in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Asparago, G; Cuozzo, F; Maffulli, N; Migliorini, F; Oliva, F | 1 |
| Chen, GH; Ma, R; Zhai, XC; Zhao, LJ | 1 |
| Chen, X; Wang, KL; Zhang, AH; Zhao, QX | 1 |
| Aoki, SK; Beckmann, JT; Hanson, JA; Kapron, AL; Maak, TG; Wylie, JD | 1 |
| Aoki, SK; Beckmann, JT; Greene, TH; Maak, TG; Potter, MQ; Wylie, JD | 1 |
| Løken, S | 1 |
| El Masry, MA; Gamie, Z; Macfarlane, RJ; Ng, BH; Schizas, C; Tsiridis, E; Velonis, S | 1 |
| de Medicis, R; Lussier, A | 1 |
| Gebuhr, P; Soelberg, M; Wilbek, H | 1 |
| Gebuhr, PH; Soelberg, M; Wilbek, H | 1 |
| Hulet, C; Joubert, JM; Vielpeau, C | 1 |
| Gebuhr, P; Orsnes, T; Soelberg, M; Wilbek, H | 1 |
3 review(s) available for naproxen and Ectopic Ossification
| Article | Year |
|---|---|
Efficacy of naproxen prophylaxis for the prevention of heterotopic ossification after hip surgery: a meta-analysis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthroplasty, Replacement, Hip; Arthroscopy; Hip Joint; Humans; Naproxen; Ossification, Heterotopic; Postoperative Complications; Randomized Controlled Trials as Topic | 2018 |
A systematic review and meta-analysis of naproxen for prevention heterotopic ossification after hip surgery.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthroplasty, Replacement, Hip; Arthroscopy; Hip Joint; Humans; Naproxen; Ossification, Heterotopic; Postoperative Complications; Randomized Controlled Trials as Topic | 2019 |
Pharmacological treatment of heterotopic ossification following hip and acetabular surgery.
Topics: Acetabulum; Anti-Inflammatory Agents, Non-Steroidal; Arthroplasty, Replacement, Hip; Celecoxib; Diclofenac; Humans; Indomethacin; Naproxen; Ossification, Heterotopic; Postoperative Complications; Pyrazoles; Sulfonamides | 2008 |
5 trial(s) available for naproxen and Ectopic Ossification
| Article | Year |
|---|---|
Effect of Naproxen Prophylaxis on Heterotopic Ossification Following Hip Arthroscopy: A Double-Blind Randomized Placebo-Controlled Trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Arthroscopy; Double-Blind Method; Drug Administration Schedule; Female; Femoracetabular Impingement; Follow-Up Studies; Humans; Male; Middle Aged; Naproxen; Ossification, Heterotopic; Postoperative Complications; Preoperative Care; Treatment Outcome; Young Adult | 2015 |
Naproxen for 8 days can prevent heterotopic ossification after hip arthroplasty.
Topics: Adult; Aged; Aged, 80 and over; Drug Administration Schedule; Hip; Hip Prosthesis; Humans; Middle Aged; Naproxen; Ossification, Heterotopic; Prospective Studies; Range of Motion, Articular; Reoperation; Statistics, Nonparametric; Treatment Outcome | 1995 |
[Eight days of naproxen therapy can prevent heterotopic ossification after total hip alloplasty].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Female; Hip Prosthesis; Humans; Male; Middle Aged; Naproxen; Ossification, Heterotopic; Postoperative Complications; Radiography | 1996 |
Naproxen in the prevention of heterotopic ossification after total hip replacement.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthroplasty, Replacement, Hip; Chi-Square Distribution; Double-Blind Method; Humans; Indomethacin; Logistic Models; Male; Middle Aged; Naproxen; Ossification, Heterotopic; Postoperative Complications; Prospective Studies; Radiography; Statistics, Nonparametric; Time Factors | 1999 |
Naproxen prevention of heterotopic ossification after hip arthroplasty. A prospective control study of 55 patients.
Topics: Administration, Oral; Adult; Aged; Double-Blind Method; Hip Prosthesis; Humans; Middle Aged; Naproxen; Ossification, Heterotopic; Postoperative Care; Preoperative Care; Prospective Studies; Suppositories; Time Factors | 1991 |
4 other study(ies) available for naproxen and Ectopic Ossification
| Article | Year |
|---|---|
A comprehensive update on the pharmacological management of heterotopic ossification following hip arthroplasty: a level I evidenced based expert opinion.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthroplasty, Replacement, Hip; Celecoxib; Diclofenac; Expert Testimony; Humans; Naproxen; Ossification, Heterotopic; Postoperative Complications | 2022 |
The Effect of NSAID Prophylaxis and Operative Variables on Heterotopic Ossification After Hip Arthroscopy.
Topics: Acetabuloplasty; Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthroscopy; Cartilage, Articular; Cohort Studies; Female; Hip Joint; Humans; Male; Naproxen; Ossification, Heterotopic; Postoperative Care; Postoperative Complications; Retrospective Studies | 2014 |
Hip Arthroscopy and Heterotopic Ossification: Is NSAID Prophylaxis Justified? Commentary on an article by James T. Beckmann, MD, MS, et al.: "Effect of Naproxen Prophylaxis on Heterotopic Ossification Following Hip Arthroscopy: A Double-Blind Randomized P
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthroscopy; Female; Femoracetabular Impingement; Humans; Male; Naproxen; Ossification, Heterotopic; Postoperative Complications; Preoperative Care | 2015 |
Correlation between ossification and inflammation using a rat experimental model.
Topics: Animals; Arthritis; Arthritis, Experimental; Disease Models, Animal; Indomethacin; Naproxen; Ossification, Heterotopic; Phenylbutazone; Rats; Spine; Spondylitis, Ankylosing | 1983 |